Humana Inc. (NYSE:HUM) Given Consensus Recommendation of “Hold” by Analysts

Humana Inc. (NYSE:HUM) has earned an average rating of “Hold” from the thirty ratings firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $386.6087.

Several research analysts have issued reports on HUM shares. Oppenheimer reiterated an “outperform” rating and set a $405.00 target price on shares of Humana in a report on Thursday. Truist Financial boosted their price target on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target for the company in a research report on Thursday. Lake Street Capital assumed coverage on shares of Humana in a research note on Thursday. They set a “buy” rating on the stock. Finally, Robert W. Baird set a $390.00 price objective on shares of Humana in a report on Thursday.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Wilkerson Advisory Group LLC raised its position in shares of Humana by 24.6% in the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after acquiring an additional 33 shares in the last quarter. CoreCap Advisors LLC grew its stake in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Bogart Wealth LLC grew its stake in Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Fiduciary Alliance LLC raised its holdings in Humana by 0.9% in the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after purchasing an additional 49 shares in the last quarter. Finally, Sanctuary Advisors LLC lifted its position in shares of Humana by 1.6% during the fourth quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after buying an additional 52 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

Shares of HUM stock opened at $364.54 on Monday. Humana has a twelve month low of $163.11 and a twelve month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a fifty day simple moving average of $370.79 and a two-hundred day simple moving average of $268.31. The stock has a market capitalization of $43.77 billion, a price-to-earnings ratio of 34.49, a P/E/G ratio of 2.08 and a beta of 0.72.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same quarter last year, the firm posted $6.27 earnings per share. On average, analysts predict that Humana will post 9.08 EPS for the current fiscal year.

Humana News Roundup

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Analyst upgrades: Leerink Partners raised Humana from “market perform” to “outperform” and set a $513 price target, implying substantial upside. Bank of America also upgraded the stock to “Buy.” Leerink Partners upgrade Bank of America upgrade
• Positive Sentiment: Second-quarter beat: Humana reported adjusted EPS of $7.61, above the $7.27 consensus estimate, while revenue reached $40.89 billion versus expectations of $40.58 billion. Revenue increased 26.2% year over year, and reported profit was approximately $694 million. Humana second-quarter profit report
• Neutral Sentiment: TD Cowen raised its target from $350 to $370 but maintained a “Hold” rating, indicating only modest expected upside and signaling limited conviction despite the higher valuation estimate. TD Cowen price target update
• Negative Sentiment: Unchanged guidance disappointed investors: Humana affirmed its full-year 2026 adjusted earnings outlook rather than raising it after the quarterly beat. Reports also cited pressure from lower Medicare Advantage quality ratings, tempering optimism about near-term earnings growth. Humana stock and second-quarter outlook
• Negative Sentiment: Medicare Advantage exits: Humana plans to withdraw from additional Medicare Advantage markets and plans in 2027 as it targets a 3% margin. The portfolio reshaping may improve profitability over time, but it could reduce membership and revenue growth in the near term. Humana Medicare Advantage plan exits

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.